The class of Vmn2r31 activators encompasses a variety of chemicals that engage with signaling pathways pertinent to the function of G-protein coupled receptors (GPCRs), such as Vmn2r31. These activators are recognized for their ability to modulate intracellular signaling cascades that are integral to the operation of GPCRs. They typically act by altering the levels of second messengers like cyclic AMP (cAMP) or by influencing the activity of enzymes and proteins that are part of the GPCR signaling framework. For instance, certain activators in this class can increase cAMP levels by directly stimulating adenylyl cyclase, which then activates protein kinase A (PKA). PKA has a role in phosphorylating various target proteins, including GPCRs themselves, which can modify GPCR activity. Others in this class can affect the function of GPCRs by altering the activity of protein kinase C (PKC), which is known to phosphorylate GPCRs and regulate their function.
Additionally, the chemical activators may act on the levels of intracellular calcium, a secondary messenger that plays a critical role in the signaling mechanisms of GPCRs. By increasing intracellular calcium concentration, some activators can influence the regulation of GPCRs. Also, some of these chemicals can affect the enzymes such as phospholipase C, which is pivotal in generating diacylglycerol (DAG) and inositol trisphosphate (IP3), both of which are vital for the function of GPCRs. Importantly, the actions of these activators are not isolated to a single signaling pathway or mechanism; rather, they can engage multiple targets and processes within the cellular signaling network, which may then converge to modulate the activity of Vmn2r31.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that stimulates adenylyl cyclase via Gs protein-coupled receptors, raising intracellular cAMP levels, which can influence GPCR signaling and could possibly activate Vmn2r31. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate GPCRs and regulate their function. PKC activation could possibly activate Vmn2r31. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Catalyzes ADP-ribosylation of Gi alpha proteins, inhibiting their activity and modifying GPCR signaling, which could possibly activate Vmn2r31. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, affecting calcium-mediated signaling pathways associated with GPCR function, and could possibly activate Vmn2r31. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, potentially enhancing GPCR signaling and could possibly activate Vmn2r31. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
An inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII), which could affect GPCR signaling and could possibly activate Vmn2r31. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
A calcium channel blocker that can reduce calcium influx, potentially affecting GPCR signaling pathways and could possibly activate Vmn2r31. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
An alpha-2 adrenergic receptor antagonist that can increase the release of norepinephrine, affecting adenylyl cyclase activity and cAMP levels, which could modulate GPCR signaling and could possibly activate Vmn2r31. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
A cholinergic agonist that can activate phospholipase C through Gq protein-coupled muscarinic receptors, leading to the production of IP3 and DAG, which may influence GPCR signaling networks and could possibly activate Vmn2r31. | ||||||